Table 4.
Measure | Difference of changes in AD+ and AD− groups between 1st and 2nd testing (interaction effect) | p | Difference of AD+ and AD− groups based on the results of the second testing (between group effect) | p | Difference of first and second testing results in AD+ group (within group effect) | p |
---|---|---|---|---|---|---|
PAL First trial memory score | 3.39 | 0.0016 | 4.11 | <0.001 | 1.80 | 0.130 ns |
PAL Mean trials to success | −0.59 | 0.0014 | −0.62 | 0.003 | −0.51 | <0.001 |
PAL Stages completed | 0.95 | <0.0001 | 1.25 | <0.001 | 0.23 | 1.00 ns |
PAL Total errors (adjusted) | −35.4 | <0.0001 | −47.3 | <0.001 | −18.3 | 0.005 |
PAL Total errors (6 shapes, adjusted) | −11.7 | 0.0002 | −17.5 | <0.001 | −7.03 | 0.008 |
PAL Total errors (8 shapes, adjusted) | −8.89 | 0.0447 | −14.2 | 0.005 | −4.67 | 1.00 ns |
PAL Total trials (adjusted) | −8.65 | <0.0001 | −9.73 | <0.001 | −4.40 | 0.002 |
PRM delayed; Number correct | 0.61 | 0.240 ns | 0.47 | 1.00 ns | 1.20 | 0.003 |
Only those CANTAB test measures were included, which correlated strongly (r>0.7) with MMSE;
ns – not significant.